gms | German Medical Science

66th Annual Meeting of the German Society of Neurosurgery (DGNC)
Friendship Meeting with the Italian Society of Neurosurgery (SINch)

German Society of Neurosurgery (DGNC)

7 - 10 June 2015, Karlsruhe

Postersitzungen
P III Freie Themen II: Gliome experimentell

Meeting Abstract (P 031)

Element distribution analysis of glioma tissue and cells by using x-ray microscopy

Sachkova A, Ducic T, Sperling S, Grolimund D, Rohde V, Ninkovic M
[Full Text]
Meeting Abstract (P 032)

CD133 expression is not synonymous with immunoreactivity for the diagnostic antibody AC133 and fluctuates throughout the cell cycle in glioma stem-like cells

Renovanz M, Barrantes-Freer A, Pardo L, Giese A, Kim EL
[Full Text]
Meeting Abstract (P 033)

Expression of plasmolipin on glioma stem-like cells confers susceptibility to gene transduction using lentiviral McERV pseudotypes

Kim E, Renovanz M, Viehweg S, Giese A, Stocking C, Prassolov V
[Full Text]
Meeting Abstract (P 034)

Role of co-chaperone BAG-1 in glioma

Müther M, Dohm C, Rave-Fränk M, Bähr M, Kermer P
[Full Text]
Meeting Abstract (P 035)

E-cadherin propeptide modification potentially determines migratory and invasive behavior of glioma cells

Ritter S, Schackert G, Temme HA
[Full Text]
Meeting Abstract (P 036)

Increased KIR4.1 immunoreactivity in human glioma tissue

Schirmer L, Ringel F, Butenschön VM, Srivastava R, Hemmer B, Gempt J
[Full Text]
Meeting Abstract (P 037)

Alteration of FGF isoform expression in glioma patients of different WHO grades

Dreher L, Goldbrunner R, Timmer M
[Full Text]
Meeting Abstract (P 038)

Differences in the expression of CD184, CD95, CD178 and CD40 in human gliomas of various grades, before and after chemotherapy

Werner J, Röhn G, Goldbrunner R, Timmer M
[Full Text]
Meeting Abstract (P 039)

Anaplastic meningiomas WHO grade III lack of somatic AKT1-mutations and show an overexpression of EGF receptors

Juratli TA, Wiedemuth R, Geiger KD, Temme A, Kirsch M, Schackert G
[Full Text]
Meeting Abstract (P 040)

A quantitative real-time PCR high resolution melting (HRM) method for evaluating the O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation status in malignant gliomas is superior to conventional methylation specific PCR in predicting clinical outcome and survival in patients with malignant glioma

Switzeny OJ, Renovanz M, Sommer C, Christmann M, Giese A, Kaina B
[Full Text]
Meeting Abstract (P 041)

No glow in the dark – why some gliomas are non-fluorescent: Histopathologic analysis of 140 high-grade gliomas

Hickmann AK, Nadji-Ohl M, Ganslandt O
[Full Text]
Meeting Abstract (P 042)

Enhancement of the temozolomide effect with atorvastatin and pioglitazone on malignant glioma

Yildiz ÖC, Pérez JHT, Kirches E, Mawrin C, Schneider T
[Full Text]
Meeting Abstract (P 043)

Overexpression of BIRC5/Survivin in glioma cells induces resistance against temozolomide and enhances tumorigenicity

Conde M, Düring I, Wiedemuth R, Schackert G, Temme A
[Full Text]